You are here:

Archived: choriogonadotropin alfa (Ovitrelle)


In the absence of a submission from the holder of the marketing authorisation

choriogonadotropin (Ovitrelle) is not recommended for use within NHS Scotland for the treatment of anovulatory or oligo-ovulatory women.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHS Scotland

Drug Details

Drug Name: choriogonadotropin alfa (Ovitrelle)
SMC Drug ID: 264/06
Manufacturer: Serono Ltd
Indication: Anovulatory or oligo-ovulatory women
BNF Category:
Sub Category: 6.5 Hypothalamic and pituitary hormones and anti-oestrogens
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 8 May 2006

Current Advice

Abbreviated Submission 9 October 2006